From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Saved in:
| Title: | From Genomic Testing to Olaparib Treatment: Real-World Utilization and Outcomes in BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. |
|---|---|
| Authors: | Bosch D; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. Dianne.Bosch@radboudumc.nl., van der Velden KJM; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Haarlem, The Netherlands., van den Berg HP; Department of Medical Oncology, Tergooi Medical Center, Hilversum, The Netherlands., Bergman AM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Doelen MJ; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands., Kerkhofs TMA; Division of Medical Oncology, Department of Internal Medicine, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., van de Luijtgaarden ACM; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Tascilar M; Department of Medical Oncology, Isala, Zwolle, The Netherlands., Vervenne WL; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Weijl NI; Department of Medical Oncology, Haaglanden Medical Center, The Hague, The Netherlands., Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Mulders PFA; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Kuppen MCP; Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Oort IM; Department of Urology, University Medical Center Groningen, Groningen, The Netherlands. |
| Source: | Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Jun; Vol. 13 (2), pp. 183-192. Date of Electronic Publication: 2026 May 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
